Search For "ph"
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupira
Updated : 5 years, 1 month ago IST
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Read More
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 5 years, 1 month ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Transcon Developers eyes Rs. 2000 crore revenue from 2nd and 3rd phase of
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 25 (ANI/BusinessWire India): After the successful delivery of their uber luxury project Transcon Triumph at Andheri West, Transcon Developers, one of the prominent real estate groups in Mumbai has recently launched its second phase. The second and third phas
Read More
Harish C Rijhwani launches his third book 'Master the Mystic Arts' - Data
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 25 (ANI/Connect360PR): Healthcare IT professional Harish C. Rijhwani launched his third book titled 'Master The Mystic Arts'.
Read More
Maruti Suzuki Podar Learn School in Sitapur, Ahmedabad set to open virtual
Updated : 5 years, 1 month ago IST
Ahmedabad (Gujarat) [India], May 24 (ANI/Hunk Golden and Media): Maruti Suzuki Podar Learn School is all set to open its doors albeit virtu-ally for the students of Sitapur, Taluka - Mandal, Dist - Ahmedabad, Gujarat in June 2021.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 3
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe, the generic version of F
Read More
Equity indices flat in volatile trade, pharma stocks gain
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 24 (ANI): Equity benchmark indices were flat in volatile trade during early hours on Monday with pharma scrips gaining some ground.
Read More
Morepen approves Rs 433 crore investment from Swiss-based Corinth
Updated : 5 years, 1 month ago IST
New Delhi [India], May 21 (ANI): Morepen Laboratories said on Friday it has approved an incoming investment of Rs 433 crore to Corinth Investment Holdings AG of Switzerland.
Read More
Syngenta launches multiple initiatives to strengthen rural health infrastr
Updated : 5 years, 1 month ago IST
New Delhi [India], May 21 (ANI/BusinessWire India): With the second wave of the Covid pandemic gripping rural India in an unprecedented crisis, the country's leading agriculture company Syngenta India has stepped in to provide support to help farmers cope with healthcare challenges.
Read More
Covid vaccines create 9 new billionaires: People's Vaccine Alliance
Updated : 5 years, 1 month ago IST
New Delhi [India], May 20 (ANI): At least nine people have become new billionaires since the beginning of Covid pandemic, thanks to the excessive profits pharmaceutical corporations with monopolies on Covid vaccines are making, the People's Vaccine Alliance said on Thursday ahead of a G20 le
Read More
Drugs manufacturer from Hyderabad on overdrive
Updated : 5 years, 1 month ago IST
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
Read More
Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2
Updated : 5 years, 1 month ago IST
New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
Read More